Status:
UNKNOWN
Epidemiology, Treatment and Prognosis of Neonatal Meningitis in Turkey: A Multicenter Study
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Conditions:
Neonatal Meningitis
Eligibility:
All Genders
Up to 30 years
Brief Summary
Meningitis, defined as inflammation of the meninges caused by different pathogens, is a serious infection associated with high morbidity and mortality. It occurs more commonly in the neonatal period t...
Eligibility Criteria
Inclusion
- Subject has a positive cerebrospinal fluid culture/PCR of bacterial pathogen.
- Subject has a positive blood culture of bacterial pathogen and counts of white blood cells in cerebrospinal fluid ≥20 /mm3.
Exclusion
- Major congenital anomalies
- Cultures positive for coagulase-negative staphylococci (CONS) were excluded as possible contaminants, if not clinically and laboratory compatible with meningitis.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04009551
Start Date
June 1 2019
End Date
October 1 2019
Last Update
July 9 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Zekai Tahir Burak Women's Health Research and Education Hospital
Ankara, Turkey (Türkiye)
2
Bursa Yuksek Ihtisas Research and Education Hospital
Bursa, Turkey (Türkiye)
3
Gazi Yasargil Education Research Hospital
Diyarbakır, Turkey (Türkiye)
4
İstanbul Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye)